Skip to content
-
Guiding Principles for Safe and Efficacious COVID-19 Vaccine Development, Distribution, Allocation, and Mass Immunization
Oct 22, 2020
NASP along with the Pharmaceutical Supply and Payment Chain Coalition offers the following guiding principles for... read more
-
National Association of Specialty Pharmacy (NASP) Inducted New Chairman of the Board and Announced Scholarship, NASP Challenge and Abstract Award Recipients During the 2020 Annual Meeting & Expo Virtual Experience
Sep 18, 2020
WASHINGTON, DC – September 18, 2020– National Association of Specialty Pharmacy (NASP) shined the spotlight on... read more
-
National Association of Specialty Pharmacy (NASP) Announces Awards and Welcomes New Board Members at the 2020 Annual Meeting & Expo Virtual Experience
Sep 15, 2020
WASHINGTON, DC – September 15, 2020 – National Association of Specialty Pharmacy (NASP) was pleased to... read more
-
NASP Supports the SAFE TO WORK ACT
Jul 30, 2020
WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
-
Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees
Jul 29, 2020
WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
-
NASP Submits Comments to CMS
Jul 23, 2020
WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
-
NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments
Jul 23, 2020
EVERSANA, the leading provider of global commercial services to the life sciences industry, today announced a partnership with ICER to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. read more
-
NASP submits comments to CMS on CMS-284-P
Jul 20, 2020
NASP submitted recommendations on sections of the rule to specifically address the needs of specialty patients and the pharmacies that serve their needs. read more
-
NASP Supports the SAFE TO WORK Act
Jun 29, 2020
NASP submitted a letter to leaders in Congress in support of the SAFE TO WORK Act. read more
-
Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees
Jun 29, 2020
NASP submitted a letter to HHS by NASP and the country's leading pharmacy groups stating that any action on a prescription drug rebate rule must address skyrocketing fees extracted by some pharmacy benefit managers on behalf of plan sponsors in Medicare Part D. read more